TIMED CAPSULES

Supermarkets are finding the blush of profits associated with the release of prescription to over-the-counter products is short-lived, especially in a competitive category like analgesics.More than one year ago, retailer expectations were high when the analgesics, Orudis KT and Actron, were introduced as OTC medications. They expected another flurry of sales activity would boost their profits and

Supermarkets are finding the blush of profits associated with the release of prescription to over-the-counter products is short-lived, especially in a competitive category like analgesics.

More than one year ago, retailer expectations were high when the analgesics, Orudis KT and Actron, were introduced as OTC medications. They expected another flurry of sales activity would boost their profits and volume in the category.

"That has not been the case," said Steve Lauder, health

Register to view the full article

test - Advanced Registered User

Already a member? .

TAGS: Walmart